Publications Filter PublicationsReports Year1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024 All categoriesAboriginal and Torres Strait Islander healthAdverse events following immunisationAIR data transfer studyAnnual coverage reportAusVaxSafetyDiphtheriaEmerging infectionsGlobal healthHaemophilus influenzae type bHajj and mass gatheringsHealth economicsHepatitis AHepatitis BHuman papillomavirusImmunisation coverageImmunisation policy and practiceImmunisation reviewsInfluenzaMeaslesMeningococcal diseaseMumpsNCIRS 20th anniversaryPaediatric Active Enhanced Disease Surveillance (PAEDS)PertussisPneumococcal diseasePoliomyelitisQ feverRefugee healthRotavirusRubellaSocial researchSpecial risk groupsSurveillanceTetanusVaccine trialsVaricella-zoster Update Publications Year Category - Any -Aboriginal and Torres Strait Islander healthAdverse events following immunisationAIR data transfer studyAnnual coverage reportAusVaxSafetyDiphtheriaEmerging infectionsGlobal healthHaemophilus influenzae type bHajj and mass gatheringsHealth economicsHepatitis AHepatitis BHuman papillomavirusImmunisation coverageImmunisation policy and practiceImmunisation reviewsInfluenzaMeaslesMeningococcal diseaseMumpsNCIRS 20th anniversaryPaediatric Active Enhanced Disease Surveillance (PAEDS)PertussisPneumococcal diseasePoliomyelitisQ feverRefugee healthRotavirusRubellaSocial researchSpecial risk groupsSurveillanceTetanusVaccine trialsVaricella-zoster Totterdell J, Phillips A, Glover C, Chidwick K, Marsh J, Snelling T, Macartney K. Safety of live attenuated herpes zoster vaccine in adults 70 to 79 years: a self-controlled case series analysis using primary care data from the MedicineInsight program. Vaccine 2020;38:3968-3979. doi: 10.1016/j.vaccine.2020.03.054. [Abstract] Phillips A, Glover C, Leeb A, Cashman P, Fathima P, Crawford C, Snelling TL, Durrheim D, Macartney K. Safety of live attenuated herpes zoster vaccine in Australian adults 70–79 years of age: an observational study using active surveillance. BMJ Open 2021;11:e043880. doi: 10.1136/bmjopen-2020-043880. [Abstract] Glover C, Crawford N, Leeb A, Wood N, Macartney K. Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety. Vaccine 2020;38:4892-4900. doi: 10.1016/j.vaccine.2020.04.056. [Abstract] Pillsbury AJ, Fathima P, Quinn HE, Cashman P, Blyth CC, Leeb A, Macartney K . Comparative post-market safety profile of adjuvanted and high-dose influenza vaccines in the elderly. JAMA Open 2020;3:e204079. doi: 10.1001/jamanetworkopen.2020.4079. [Full text] Jacoby P, Glover C, Damon C, Fathima P, Pillsbury A, Durrheim D, Gold M, Leeb A, Snelling T. Timeliness of signal detection for adverse events following influenza vaccination in young children: a simulation case study. BMJ Open 2020;10:e031851. doi: 10.1136/bmjopen-2019-031851. [Full text] Cashman P, Munnoch S, Clark K, Allan N, Clarke S, Macartney K, Durrheim DN. The Aboriginal gap in online active vaccine safety surveillance. Australian Indigenous Health Bulletin 2020;1. https://ro.ecu.edu.au/aihhealthbulletin/vol1/iss1/3. [Full text] Cashman P, Moberley S, Chee K, Stephenson J, Chaverot S, Martinelli J, Gadsden T, Bateman-Steel C, Redwood L, Howard Z, Ferson MJ, Durrheim DN . Participant centred safety surveillance of health care workers receiving influenza vaccination. Vaccine 2019;37:2427-2429. doi: 10.1016/j.vaccine.2019.02.082. [Abstract] Crawford NW, Hodgson K, Gold M, Buttery J, Wood N. Adverse events following HPV immunisation in Australia: establishment of a clinical network. Human Vaccines and Immunotherapeutics 2016;12:2662-5.. [Full text] Pillsbury A, Glover C, Jacoby P, Quinn HE, Fathima P, Cashman P, Leeb A, Blyth CC, Gold MS, Snelling T, Macartney K. Active surveillance of 2017 seasonal influenza vaccine safety in individuals aged 6 months and older in Australia. BMJ Open 2018;8:e023263. doi: 10.1136/bmjopen-2018-023263. [Full text] Pillsbury A, Quinn H, Cashman, Leeb A, Macartney K. Active SMS-based influenza vaccine safety surveillance in Australian children. Vaccine 2017;35:7101-7106. doi: 10.1016/j.vaccine.2017.10.091. [Full text] Pagination Previous page ‹‹ You're on Page 2 Next page ››